FindMyKOL
Clinical trialNCT05165108TerminatedInterventional

Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study

NCT05165108 is an interventional trial sponsored by Indiana University. As of 21 Nov 2026, it was terminated. It studies Crohn Disease. The registry lists an enrollment of 4 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2021 and a primary completion date of 12 Aug 2022.

SponsorIndiana University →Enrollment4Crohn Disease
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05165108
FieldValue
Registry IDNCT05165108
StatusTerminated
Study typeInterventional trial
Lead sponsorIndiana University
Enrollment4
Registered sites1
Countries1
ConditionsCrohn Disease
Start30 Nov 2021
Primary completion12 Aug 2022
Study completion12 Aug 2022
Last update posted6 Mar 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To assess the safety and efficacy of transcutaneous vagal stimulation in adult patients with active Crohn's disease.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Indiana, United States1 site
  • Indiana University

    Indianapolis

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndiana: 1 siteIN1OhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05165108

Each answer restates registry values shown on this page.

What is NCT05165108?

NCT05165108 is an interventional trial sponsored by Indiana University. It studies Crohn Disease.

Who leads NCT05165108?

The registry names Sashidhar V Sagi, MD (principal investigator, Indiana University) and Thomas V Nowak, MD (principal investigator, Indiana University) as overall officials.

Where does NCT05165108 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT05165108 end?

The registry lists a primary completion date of 12 Aug 2022 and a study completion date of 12 Aug 2022. The sponsor last updated the record on 6 Mar 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.